Acacia Pharma Ltd, which specialises in drugs for cancer supportive care, has raised $10 million in a Series A financing round supported by the new investor, Lundbeckfond Ventures. Gilde Healthcare also participated in the round. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
